Triamcinolone Acetonide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Triamcinolone Acetonide Injection (injection) from Harrow Eye, LLC with status Resolved. The shortage was first posted on 09/27/2021.
Shortage Details
- Status
- Resolved
- Company
- Harrow Eye, LLC
- Package NDC
- 82667-800-01
- Dosage Form
- Injection
- Presentation
- Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01)
- Initial Posting
- 09/27/2021
- Revised Date